VISN
TECHNOLOGYGyroscope Therapeutics Holdings plc
$12.21-0.07 (-0.57%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving VISN Today?
No stock-specific AI insight has been generated for VISN yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$2.54$13.22
$12.21
Fundamentals
Market Cap$2.8B
P/E Ratio18.0
EPS$0.68
Dividend Yield—
Dividend / Share—
ROE0.1%
Profit Margin3.5%
Debt / Equity—
Trading
Volume9.8M
Avg Volume (10D)—
Shares Outstanding225.6M
VISN News
20 articles- Vistance Networks Stockholders Approve Proxy ProposalsYahoo Finance·May 7, 2026
- Amphenol (APH): 12 Best Growth Stocks to Invest In for the Next 2 YearsYahoo Finance·May 7, 2026
- A Look At Vistance Networks (VISN) Valuation After Recent Share Price VolatilityYahoo Finance·May 2, 2026
- Is It Time To Reassess Vistance Networks (VISN) After Its Recent Share Price Slump?Yahoo Finance·May 2, 2026
- Vistance (VISN) Q1 2026 Earnings TranscriptMotley Fool·May 1, 2026
- Vistance Surpasses Q1 Earnings Estimates on Healthy Aurora GrowthYahoo Finance·May 1, 2026
- Vistance (VSN) to Distribute New Round of Dividends, Soars 22%Yahoo Finance·May 1, 2026
- Apple Earnings Become Sideshow With New CEO Ready to Grab ReinsYahoo Finance·Apr 30, 2026
- Amphenol Corporation Q1 2026 Earnings Call SummaryMoby·Apr 30, 2026
- Vistance Networks Reports First Quarter 2026 ResultsYahoo Finance·Apr 30, 2026
- Belden to Acquire RUCKUS Networks from Vistance Networks, Accelerating its Transformation into a Full-Stack Networking Solutions ProviderYahoo Finance·Apr 30, 2026
- Vistance Networks to Sell its RUCKUS Networks Business to Belden Inc. for $1.846 BillionYahoo Finance·Apr 30, 2026
- Amphenol Making Its Name Among AI Infrastructure Space, Here Is What the Analyst Thinks?Yahoo Finance·Apr 30, 2026
- Amphenol Q1 Earnings Call HighlightsMarketbeat·Apr 30, 2026
- Amphenol forecasts upbeat quarterly results on AI data center demandYahoo Finance·Apr 29, 2026
- Vistance Networks (VISN) Loses 49% After $10 DividendYahoo Finance·Apr 29, 2026
- Ribbon Communications (RBBN) Reports Q1 Loss, Misses Revenue EstimatesYahoo Finance·Apr 28, 2026
- Did Amphenol’s Expanded AI Data Center Role and CCS Deal Just Shift Amphenol's (APH) Investment Narrative?Yahoo Finance·Apr 24, 2026
- Will Earnings Give Amphenol Stock The Push It Needs To Break Out?Yahoo Finance·Apr 17, 2026
- RUCKUS Networks and Nokia Announce Early Access Availability for their Combined Solution—an Integrated Wi-Fi 7 and Fiber Optical LAN SolutionYahoo Finance·Apr 13, 2026
All 20 articles loaded
Price Data
Open$12.90
Previous Close$12.28
Day High$12.92
Day Low$11.90
52 Week High$13.22
52 Week Low$2.54
52-Week Range
$2.54$13.22
$12.21
Fundamentals
Market Cap$2.8B
P/E Ratio18.0
EPS$0.68
Dividend Yield—
Dividend / Share—
ROE0.1%
Profit Margin3.5%
Debt / Equity—
Trading
Volume9.8M
Avg Volume (10D)—
Shares Outstanding225.6M
About Gyroscope Therapeutics Holdings plc
Gyroscope Therapeutics Holdings plc, a clinical-stage gene therapy company, develops gene therapy products to treat patients with eye diseases. The company is headquartered in Stevenage, the United Kingdom.
TECHNOLOGYCOMMUNICATION EQUIPMENT
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICCOMMUNICATION EQUIPMENT
CIK—
Composite FIGI—
Share Class FIGI—